| Flow cytometry: basic principles and applications A Adan, G Alizada, Y Kiraz, Y Baran, A Nalbant Critical reviews in biotechnology 37 (2), 163-176, 2017 | 1184 | 2017 |
| Major apoptotic mechanisms and genes involved in apoptosis Y Kiraz, A Adan, M Kartal Yandim, Y Baran Tumor Biology 37, 8471-8486, 2016 | 563 | 2016 |
| Cell proliferation and cytotoxicity assays A Adan, Y Kiraz, Y Baran Current pharmaceutical biotechnology 17 (14), 1213-1221, 2016 | 511 | 2016 |
| Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells Y Kiraz, VS Neergheen-Bhujun, N Rummun, Y Baran Tumor Biology 37, 1803-1815, 2016 | 29 | 2016 |
| An update on molecular biology and drug resistance mechanisms of multiple myeloma P Mutlu, Y Kiraz, U Gündüz, Y Baran Critical reviews in oncology/hematology 96 (3), 413-424, 2015 | 23 | 2015 |
| Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth NG Amuk, G Kurt, Y Baran, V Seyrantepe, MK Yandim, A Adan, SA Demir, ... European Journal of Orthodontics 39 (3), 235-242, 2017 | 22 | 2017 |
| Flavonoids in cancer therapy: Current and future trends SB Gürler, Y Kiraz, Y Baran Biodiversity and biomedicine, 403-440, 2020 | 12 | 2020 |
| Multidrug resistance in chronic myeloid leukemia M Ünlü, Y Kiraz, FN Kaci, MA Özcan, Y Baran Turkish Journal of Biology 38 (6), 806-816, 2014 | 12 | 2014 |
| T cells in tumor microenvironment Y Kiraz, Y Baran, A Nalbant Tumor Biology 37 (1), 39-45, 2016 | 10 | 2016 |
| Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cells FN Kacı, Y Kiraz, D Cekdemir, Y Baran Archives of Medical Research 51 (3), 187-193, 2020 | 4 | 2020 |
| Role of Polyunsaturated Fatty Acids in Cancer and Their Use in Cancer Treatment. GT Ulu, Y Kiraz, Y Baran Reviews in Clinical Medicine 6 (3), 2019 | 3 | 2019 |
| Therapeutic potentials of inhibition of Jumonji C domain-containing demethylases in acute myeloid leukemia D Koca, N Hastar, S Engür, Y Kiraz, GT Ulu, D Cekdemir, Y Baran Turkish Journal of Hematology 37 (1), 5, 2020 | 2 | 2020 |
| Personalized biomedicine in cancer: from traditional therapy to sustainable healthcare GT Ulu, Y Kiraz, Y Baran Biodiversity and Biomedicine, 441-457, 2020 | 2 | 2020 |
| Molecular characterization of multiple myeloma BZ Kiremitci, ES Gürler, Y Kiraz Journal of Medical Science 91 (2), e656-e656, 2022 | 1 | 2022 |
| Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patients Y Kiraz PQDT-Global, 2014 | 1 | 2014 |
| Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach C Ergun, BZ Kiremitci, G ARSLANTAŞ, B Bozkurt, GA Duran, Y KİRAZ Experimed 13 (3), 205-212, 2023 | | 2023 |
| In Silico Approach for Identification of PI3K/mTOR Dual Inhibitors for Multiple Myeloma Treatment İ MAŞALACI, Y Akdoğan, Ö MUTLU, H Eyvaz, Y KİRAZ European Journal of Biology 82 (1), 1-11, 2023 | | 2023 |
| Tumor-specific genetic profiling and therapy in biomedicine E Uzuner, Y Kiraz, Y Baran Biodiversity and Biomedicine, 459-485, 2020 | | 2020 |
| Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells SB Gürler, Y Baran, Y Kiraz British Journal of Haematology, 2020 | | 2020 |
| PS930 SENSITIZATION OF PH+ ALL RESISTANT TO IMATINIB BY TARGETING SPHINGOLIPID METABOLISM Y Kiraz, Y Baran, C Luberto HemaSphere 3 (S1), 419, 2019 | | 2019 |
Yusuf Baranİzmir Institute of TechnologyVerified email at iyte.edu.tr
